Back to News
investment

Columbia Select Large Cap Growth Fund Q4 2025 Commentary

Seeking Alpha
Loading...
1 min read
0 likes
⚡ Quantum Brief
The Columbia Select Large Cap Growth Fund posted a 1.16% return for Q4 2025, slightly outperforming the Russell 1000 Growth Index’s 1.12% gain during the same period. The Federal Reserve cut interest rates by 0.25% in both October and December 2025, continuing its policy easing as economic conditions stabilized. Market leadership shifted away from mega-cap tech stocks, marking a broader rally where biotech and pharma sectors gained prominence as key performance drivers. Biotech holdings Argenx and Insmed, alongside pharma giant Eli Lilly, delivered outsized returns, outperforming the fund’s broader portfolio during the quarter. The fund maintained its focus on durable secular growth companies, avoiding cyclical and commoditized sectors to prioritize long-term stability.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (34).png
Quantum News · Media Library

Columbia Threadneedle Investments1.01K FollowersFollow5ShareSavePlay(10min)CommentsSummaryColumbia Select Large Cap Growth Fund Institutional Class shares returned 1.16% for the three months ending December 31, 2025.The U.S. Federal Reserve continued to ease policy, cutting rates by a quarter point at its meetings in October and December.The quarter was characterized by a broadening of leadership away from the mega-cap technology stocks that had been key drivers of market performance.Our holdings in biotechnology firms Argenx and Insmed (INSM) and pharma leader Eli Lilly all delivered strong returns and were relative outperformers.We continue to be invested in very durable secular growth names versus generally more cyclical and commoditized names. Funtap/iStock via Getty Images Fund performance Columbia Select Large Cap Growth Fund Institutional Class shares returned 1.16% for the three months ending December 31, 2025. The Russell 1000 Growth Index returned 1.12% during the same period. Market overviewThis article was written byColumbia Threadneedle Investments1.01K FollowersFollowColumbia Threadneedle Investments is a leading global asset management group that provides a broad range of actively managed investment strategies and solutions for individual, institutional and corporate clients around the world.

Columbia Threadneedle Investments is the global asset management group of Ameriprise Financial, Inc. (NYSE: AMP). For more information please visit columbiathreadneedleus.com.

Read Original

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.